MedTech
Why Robinhood?
You can watch MedTech and buy or sell other stocks, ETFs, and their options commission-free!About MTAC
TriSalus Life Sciences, Inc. is an oncology company, which engages in the business of integrating standard-of-care treatments and investigational immunotherapeutic with disruptive pressure enabled drug delivery infusion systems to transform the treatment paradigm for patients battling liver and pancreatic tumors. The company was founded on September 11, 2020 and is headquartered in Westminster, CO.
MTAC Key Statistics
Stock Snapshot
MedTech(MTAC) stock is priced at $4.43, giving the company a market capitalization of 221.49M. It carries a P/E multiple of -2.42.
On 2026-05-09, MedTech(MTAC) stock opened at —, reached a high of —, and a low of —.
The MedTech(MTAC)'s current trading volume is 0, compared to an average daily volume of 99.36K.
During the past year, MedTech(MTAC) stock moved between $3.42 at its lowest and $7.95 at its peak.
During the past year, MedTech(MTAC) stock moved between $3.42 at its lowest and $7.95 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.